Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT Alternate Symbol(s):  V.TLT.W

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:TLT)

Theralase advances cancer research after private placement

Jonathon Brown 2 days ago

Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement

Accesswire 2 days ago

This company’s Photo Dynamic Therapy is transforming cancer treatment

Jocelyn Aspa April 9, 2024

Theralase patents new cancer vaccine in Canada

Trevor Abes  April 5, 2024

Theralase(R) Granted Canadian Cancer Vaccine Patent

Accesswire April 5, 2024

Theralase(R) Release's 4Q2023 Interim Financial Statements

Accesswire March 27, 2024

Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association

Accesswire March 26, 2024

Theralase donates laser therapy tech to help research Parkinson’s treatment

Jonathon Brown February 12, 2024

Theralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's Disease

Accesswire February 12, 2024
View More News ››

Opinion & Analysis (TSXV:TLT)

Pharmaceutical company treats bladder cancer with new tech

Ryan Dhillon January 8, 2024

Theralase is raising up to $5.3M to complete bladder cancer study

Coreena Robertson November 6, 2023

For Better or Worse? On the Verge of a New Era in Investing

Stockhouse Editorial April 1, 2021

Buzz on the Bullboards: A Big Picture Look at Small-Cap Opportunities

Stockhouse Editorial February 18, 2021

Buzz on the Bullboards: Tracking the Big Movers of 2020

Stockhouse Editorial December 17, 2020

Buzz on the Bullboards: T’is the Season for a Rebound?

Stockhouse Editorial December 3, 2020
View More Opinion ››

Bullboard Posts (TSXV:TLT)

RE:RE:RE:RE:RE:RE:RE:It won't be long now..

Anybody familiar  with Apotech story?
Alamir1111 - 3 minutes ago

RE:RE:RE:RE:It won't be long now..

The communist dictator south of border ready to pull same sh-t with our capital gains tax
Legit62 - 4 minutes ago

RE:RE:RE:RE:RE:RE:It won't be long now..

I like hard cash up front and if we get shares of company buying us would be bonus, cash is king
Legit62 - 5 minutes ago

RE:RE:RE:RE:RE:RE:It won't be long now..

Good lesson here to be a drug dealer you need to buy from source Ex, buy bcg from source juice it up with some sh.than sell it for profit...
Alamir1111 - 31 minutes ago

RE:RE:RE:RE:RE:It won't be long now..

Sorry forgot 3.5 mil s taxable at 50% = 1.75 mil +3.25 =5 mil.Looking at nr.for all those years invested adding the pain anguish ...
Alamir1111 - 37 minutes ago

RE:RE:RE:RE:RE:It won't be long now..

That's one of the big reasons why it should be a (non-taxable) stock exchange rather than a cash buyout, if and when it happens. ...
menoalittle - 47 minutes ago
View more Bullboard ››

Acceleware Ltd

Acceleware Ltd

Acceleware Ltd. is a Canada-based company that develops clean-tech decarbonization technologies. The Company has two business ...
View More »